FDA Inspection
Gland Pharma LimitedGland Pharma Limited – FDA Inspection, Mar 31, 2017
Record Details
This FDA Inspection record concerns Gland Pharma Limited, with an inspection on March 31, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · f11bc613-6f2c-4144-ad0f-51acc97a860d
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1010051
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Gland Pharma Limited
7| Date | Classification | Office | Project area |
|---|---|---|---|
| July 28, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 15, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 18, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 30, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gland Pharma Limited
- FDA Inspection 1220251 - 2023-07-28
- FDA Inspection 1110628 - 2019-11-01
- FDA Inspection 1061075 - 2018-06-15
- FDA Inspection 1056489 - 2018-05-18
- FDA Inspection 936901 - 2015-06-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.